• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于降低透析单元丙型肝炎患病率的方法。

Methods used to reduce the prevalence of hepatitis C in a dialysis unit.

作者信息

Hussein Magdi M, Mooij Jaap M

机构信息

Department of Nephrology, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.

出版信息

Saudi J Kidney Dis Transpl. 2010 Sep;21(5):909-13.

PMID:20814130
Abstract

In the present study, we report on the follow-up of the epidemiology of hepatitis C viremia in our dialysis unit after our previous report, over the period from July 1, 2003 to December 31, 2005. The methods to reduce the prevalence of hepatitis C viremia in our center included: strict adherence to universal infection control precautions, separation of hepatitis C virus (HCV) positive patients from the negative patients and using specially designated machines for them, and from July 2003, periodic testing of all patients for HCV-RNA. Following the application of the above mentioned methods, we have not had, since 31 December 2005, any case of sero-conversion from HCV-negative to HCV-positive in our dialysis unit and the only HCV-positive patients present were those who were already positive at entry. The overall prevalence of HCV-RNA positive patients in our unit has presently come down to 6.5%. Although isolation and use of designated machines for HCV-RNA positive patients is not recommended following the latest guidelines of "Kidney Disease: Improving Global Outcomes" (KDIGO, 2008), the present study supports previous reports that these measures might be beneficial, when there is a high prevalence of HCV-RNA positive patients, and in units where due to understaffing or other causes, break in infection control procedures is likely to occur.

摘要

在本研究中,我们报告了自上次报告以来,2003年7月1日至2005年12月31日期间我们透析单元丙型肝炎病毒血症的流行病学随访情况。我们中心降低丙型肝炎病毒血症患病率的方法包括:严格遵守普遍的感染控制预防措施,将丙型肝炎病毒(HCV)阳性患者与阴性患者分开,并为他们使用专门指定的机器,并且自2003年7月起,对所有患者定期进行HCV-RNA检测。在应用上述方法后,自2005年12月31日以来,我们的透析单元没有出现过任何从HCV阴性血清转化为HCV阳性的病例,目前存在的唯一HCV阳性患者是那些入院时就已呈阳性的患者。我们单元中HCV-RNA阳性患者的总体患病率目前已降至6.5%。尽管根据《肾脏病:改善全球预后》(KDIGO,2008)的最新指南,不建议对HCV-RNA阳性患者进行隔离并使用指定机器,但本研究支持先前的报告,即当HCV-RNA阳性患者患病率较高时,以及在由于人员不足或其他原因可能发生感染控制程序中断的单位中,这些措施可能是有益的。

相似文献

1
Methods used to reduce the prevalence of hepatitis C in a dialysis unit.用于降低透析单元丙型肝炎患病率的方法。
Saudi J Kidney Dis Transpl. 2010 Sep;21(5):909-13.
2
The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit.聚合酶链反应检测法对血液透析单位丙型肝炎病毒感染检测的影响
Saudi J Kidney Dis Transpl. 2007 Mar;18(1):107-13.
3
Prevention of hepatitis C virus in hemodialysis patients: five years experience from a single center.血液透析患者丙型肝炎病毒的预防:单中心五年经验
Saudi J Kidney Dis Transpl. 2010 May;21(3):548-54.
4
Prevention of viral transmission in HD units: the value of isolation.预防血液透析单位中的病毒传播:隔离的价值。
Saudi J Kidney Dis Transpl. 2006 Jun;17(2):183-8.
5
Hepatitis C infection in dialysis patients in Israel.以色列透析患者中的丙型肝炎感染情况。
Isr Med Assoc J. 2001 Mar;3(3):174-7.
6
[Viral hepatitis in hemodialysis patients].[血液透析患者中的病毒性肝炎]
Rinsho Byori. 2001 Mar;49(3):249-53.
7
Universal precautions and dedicated machines as cheap and effective measures to control HCV spread.普遍预防措施和专用机器是控制丙型肝炎病毒传播的廉价且有效措施。
EDTNA ERCA J. 1998 Apr-Jun;24(2):43-5, 48.
8
Effect of isolation measures on the incidence and prevalence of hepatitis C virus infection in hemodialysis.隔离措施对血液透析中丙型肝炎病毒感染发病率和患病率的影响。
Nephron Clin Pract. 2006;104(1):c1-6. doi: 10.1159/000093252. Epub 2006 May 9.
9
Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the Southwest Parana State, Brazil.巴西巴拉那州西南部慢性血液透析患者中急性丙型肝炎病毒感染的评估
BMC Public Health. 2007 Apr 4;7:50. doi: 10.1186/1471-2458-7-50.
10
Hepatitis C virus in chronic dialysis patients.慢性透析患者中的丙型肝炎病毒
Minerva Urol Nefrol. 2005 Sep;57(3):175-97.

引用本文的文献

1
Hepatitis B and hepatitis C testing practices and observed seroconversions among dialysis facilities in Georgia.佐治亚州透析机构的乙肝和丙肝检测实践及观察到的血清转化情况。
J Infect Prev. 2024 Sep;25(5):182-187. doi: 10.1177/17571774241239777. Epub 2024 Mar 16.
2
Questionnaire-based analysis of infection prevention and control in healthcare facilities in Saudi Arabia in regards to Middle East Respiratory Syndrome.基于问卷调查对沙特阿拉伯医疗机构中东呼吸综合征感染预防与控制情况的分析
J Infect Public Health. 2017 Sep-Oct;10(5):548-563. doi: 10.1016/j.jiph.2016.11.008. Epub 2017 Feb 16.
3
Management of hepatitis C virus infection in hemodialysis patients.
血液透析患者丙型肝炎病毒感染的管理
World J Hepatol. 2014 Jun 27;6(6):419-25. doi: 10.4254/wjh.v6.i6.419.
4
Compliance of healthcare professionals with safety measures for control of hepatitis viruses in hemodialysis centers: an experience from southeast iran.血液透析中心医护人员对控制肝炎病毒安全措施的依从性:来自伊朗东南部的经验
Hepat Res Treat. 2012;2012:415841. doi: 10.1155/2012/415841. Epub 2012 Nov 8.
5
Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?沙特阿拉伯病毒性肝炎的流行病学:我们是否摆脱困境了?
Saudi J Gastroenterol. 2012 Nov-Dec;18(6):349-57. doi: 10.4103/1319-3767.103425.
6
SASLT practice guidelines: management of hepatitis C virus infection.SASLT实践指南:丙型肝炎病毒感染的管理
Saudi J Gastroenterol. 2012 Sep;18 Suppl(Suppl 1):S1-32. doi: 10.4103/1319-3767.101155.